Prognostic value of nucleolar organizer regions in supraglottic carcinoma

Auris Nasus Larynx

Volumn 24, Issue 1, 1997, Pages 85-90

  Yamamoto, Yuzo ^a   Itoh, Takashi ^a   Saka, Tetsuro ^a   Sakakura, Atsushi ^a   Takahashi, Hiroaki ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Lymph node metastasis; Nucleolar organizer regions; Supraglottic carcinomas

Indexed keywords

ARTICLE; CANCER GROWTH; CHROMOSOME NOR; GLOTTIS; HUMAN; HUMAN TISSUE; LARYNX CARCINOMA; LYMPH NODE METASTASIS; TUMOR DIFFERENTIATION;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; GLOTTIS; HUMANS; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0030981619     PISSN: 03858146     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0385-8146(96)00001-6     Document Type: Article

References (26)

1. Holm LE. Cellular DNA amounts of squamous cell carcinomas of the head and neck region in relation to prognosis. Laryngoscope 1982;92:1064-1069.
2. Goldsmith MN, Cresson DH, Postma DS et al. Significance of ploidy in laryngeal cancer. Am J Surg 1986;152:397-402.
3. Feinmesser P, Freeman J, Noyek A. Flow cytometric analysis of DNA content in laryngeal cancer. J Laryngol Otol 1990;104:485-487.
4. Yasuda N, Omori A, Goto T et al. Prognostic significance of the DNA ploidy of the early glottic cancer. J Otolaryngol Jpn 1990;93:1171-1178 (in Japanese).
5. Walter MA, Peters GE, Peiper SC. Predicting radioresistance in early glottic squamous cell carcinoma by DNA content. Ann Otol Rhinol Laryngol 1991;100:523-526.
6. Miyahara H, Minami Y, Ueda K et al. The prognostic significance of nuclear DNA content and oncogene amplification in head and neck cancer. Head Neck Cancer 1993;19:52-58 (in Japanese).
7. Chauvel P, Courdi A, Gioanni J et al. The labelling index: a prognostic factor in head and neck carcinoma. Radiother Oncol 1989;14:231-237.
8. Balzi M, Ninu BM, Becciolini A et al. Labeling index in squamous cell carcinoma of the larynx. Head Neck 1991;13:344-348.
9. Howell WM, Black DA. Controlled silver staining of nucleolus organizer regions with protective colloid developer: a one-step method. Experientia 1980;36:1014-1015.
10. Ploton D, Menager M, Jeannesson P et al. Improvement in the staining and visualization of the argyrophilic proteins of the nucleolar organizer region at the optical level. Histochem J 1986;18:5-14.
11. Crocker J, Skilbeck N. Nucleolar organizer region associated proteins in melanotic lesions of the skin. J Clin Pathol 1987;40:885-889.
12. Crocker J, Macartney JC, Smith PJ. Correlation between DNA flow cytometric and nucleolar organizer region data in non-Hodgkin's lymphomas. J Pathol 1988;154:151-156.
13. Derenzini M, Romagnoli T, Mingazzini P et al. Interphasic nucleolar organizer region distribution as a diagnostic parameter to differentiate benign from malignant epithelial tumors of human intestine. Virchows Arch B Cell Pathol 1988;54:334-340.
14. Papadimitiou CS, Athanasiadou S, Stylianidou A et al. Nucleolar organizer regions in the normal, hyperplastic and carcinomatous epithelium of endometrium. Virchows Arch B Cell Pathol 1991;60:155-160.
15. Orita T, Kajiwara K, Nishizaki T et al. Nucleolar organizer regions in meningioma. Neurosurgery 1990;26:43-46.
16. Moran K, Cooke T, Forster G et al. Prognostic value of nucleolar organizer regions and ploidy values in advanced colorectal cancer. Br J Surg 1990;76:1152-1155.
17. Rüschoff J, Bittinger A, Neumann K et al. Prognostic significance of nucleolar organizing regions (NORs) in carcinomas of the sigmoid colon and rectum. Pathol Res Pract 1990;186:85-91.
18. Sano K, Takahashi H, Fujita S et al. Prognostic implication of silver-binding nucleolar organizer regions (AgNORs) in oral squamous cell carcinoma. J Oral Pathol Med 1991;20:53-56.
19. International Union Against Cancer (UICC). In: Hermanek P and Sobin LH, editors. TNM classification of malignant tumours, 4th ed. Berlin: Springer, 1987.
20. Das BC, Rani R, Mitra AB et al. The number of silver-staining NORs (rDNA) in lymphocytes of newborns and its relationship to human development. Mech Ageing Dev 1986;36:117-123.
21. Tanaka T, Takeuchi T, Nishikawa A et al. Nucleolar organizer regions in hepatocarcinogenesis induced by N-2-fluorenylacetamide in rats: comparison with bromodeoxyuridine immunohistochemistry. Jpn J Cancer Res 1989;80:1047-1051.
22. Trerè D. Farabegoli F, Cancellieri A et al. AgNOR area in interphase nuclei of human tumours correlates with the proliferative activity evaluated by bromodeoxyuridine labelling and Ki-67 immunostaining. J Pathol 1991;165:53-59.
23. Rüschoff J, Neumann K, Contractor H et al. Assessment of nucleolar organizer regions by automatic analysis in breast cancer: correlation with DNA content, proliferation rate, receptor status and histopathological grading. J Cancer Res Clin Oncol 1990;116:480-485.
24. Bryan RL, Allcock RA, Crocker J et al. Nucleolar organizer regions in squamous tumours of the pharynx and larynx. J Clin Pathol 1989;42:218.
25. Gillen P, Grace P, Dervan P et al. Nucleolar organizer regions predict metastases in prostatic cancer. Br J Surg 1988;75:1263.
26. Bockmühl U, Theissig F, Dimmer V et al. The impact of nucleolar organizer regions for the lymph node spread and prognosis of invasive ductal mammary carcinoma. Path Res Pract 1991;187:437-443.